From various studies, it is known that cancer screening is an effective strategy for early detection and beneficial reduce mortality due to cancer. Especially for breast cancer, known to be useful screening examination reduce mortality (death) of 26-39%.
At the beginning of this year (2010), The Society of Breast Imaging (SBI) and the American College of Radiology (ACR) issued the latest recommendations on cancer screening recommendations are somewhat different from the recommendations issued by the U.S. Preventive Services Task Force (USPSTF). One difference is the age recommendation did screening with mammography, in which the USPSTF recommends beginning at age 50 years, whereas the SBI recommendations – ACR since the age of 40 years.
The following points – points recommendations: (SBR – ACR)
1. Mammography
* Women not at high risk: is done every year since the age of 40 years
* Women with high risk: women who have BRCA1 / BRCA2 mutation or an unknown but you kandunganya in 1 lineage (mother / brother / son) are known to experience mutation.: Done every year since the age of 30 years (but not at age <25 years)
* Women with risk ≥ 20% in life (lifetime) based on family history: done every year since the age of 30 years (but not at age <25 years).
Women with a family history (mother / siblings) to develop breast cancer during pre-menopause: is done every year since the age of 30 years (but not at age <25 years) or 10 years earlier than the age when the mother / brother kandunganya diagnosed with breast cancer.
* Women who never get radiotherapy chest area (generally people with Hodgkin’s lymphoma): done every year beginning 8 years after radiotherapy, but not at age below 25 years.
* Women with a history of breast tumor biopsies and showed abnormalities (lobular neoplasia / atypical ductal hyperplasia / ductal carcinoma in situ / invasive breast cancer / ovarian cancer): every year since the diagnosis regardless of age.
* Women with high risk: women who have BRCA1 / BRCA2 mutation or an unknown but you kandunganya in 1 lineage (mother / brother / son) are known to experience mutation.: Done every year since the age of 30 years (but not at age <25 years)
* Women with risk ≥ 20% in life (lifetime) based on family history: done every year since the age of 30 years (but not at age <25 years).
Women with a family history (mother / siblings) to develop breast cancer during pre-menopause: is done every year since the age of 30 years (but not at age <25 years) or 10 years earlier than the age when the mother / brother kandunganya diagnosed with breast cancer.
* Women who never get radiotherapy chest area (generally people with Hodgkin’s lymphoma): done every year beginning 8 years after radiotherapy, but not at age below 25 years.
* Women with a history of breast tumor biopsies and showed abnormalities (lobular neoplasia / atypical ductal hyperplasia / ductal carcinoma in situ / invasive breast cancer / ovarian cancer): every year since the diagnosis regardless of age.
Termination of Screening Mammography
Mamomografi annual screening is considered no longer need to be done if:
• If the life expectancy estimated at less than 5 to 7 years based on age and comorbid diseases.
• If abnormal results of mammography will not be followed up because of age or comorbid disease.
2. Ultrasonography (USG)
* Able to be considered in women at high risk in which the examination magnetic resonance imaging (MRI). Encouraged but can not be done for any reason.
* Able to be considered in women with dense breast tissue in addition / complement mammography examination.
* Able to be considered in women with dense breast tissue in addition / complement mammography examination.
3. Magnetic Resonance Imaging (MRI)
* Conducted every year since the age of 30 years in patients with: BRCA mutations (self / sibling) or high risk (> 20%).
* Conducted every year starting 8 years after patients received radiotherapy chest area (generally people with Hodgkin’s lymphoma).
* Conducted a one-time screening only in women with newly diagnosed breast cancer on one side but on the other side of the breast was not detected either by physical examination or conventional radiological examinations.
* Able to be considered in women with a risk of 15-20% of breast cancer based on personal history of breast cancer / ovarian / biopsy results neoplasia.
* Conducted every year starting 8 years after patients received radiotherapy chest area (generally people with Hodgkin’s lymphoma).
* Conducted a one-time screening only in women with newly diagnosed breast cancer on one side but on the other side of the breast was not detected either by physical examination or conventional radiological examinations.
* Able to be considered in women with a risk of 15-20% of breast cancer based on personal history of breast cancer / ovarian / biopsy results neoplasia.
In addition to screening with radiolodi examination, certainly must not forget breast self examination (BSE) is carried out every month, where if the palpable lump should consult with a physician.
Related posts:
Leave a Reply